This workbook investigates the methodological integration of economic analysis into cancer clinical trials to improve the efficiency and value of oncological research. The National Cancer Institute and the American Society of Clinical Oncology convened a working group of experts to establish a standardized framework for researchers. By addressing the complexities of cost-effectiveness and resource allocation, the text provides a structured approach for incorporating economic evaluations into the design and implementation of clinical studies.

Experts recognize this workbook as a foundational resource for clinical investigators seeking to bridge the gap between medical efficacy and economic viability. Readers frequently note the technical density of the prose, which is intended for professionals and researchers operating within the oncology field.